A fusion CyRPA-RIPR protein in combination with RH5: a novel tripartite blood-stage malaria vaccine candidate (in preparation)
Attributed to:
Investigation of the Plasmodium falciparum RH5-Interacting Protein (RIPR) as a blood-stage malaria vaccine target
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: TBC
Parent Publication: TBC
Issue: TBC